Abstract: In recent years, the number of poorly soluble drug entities coming out of drug discovery has increased significantly. These molecules demand utilization of different approaches to increase their solubility and/or dissolution rate and thus oral bioavailability. Fenoﬁbrate (FNB) is a lipophillic drug used in hypercholesterolemia and hypertriglyceridemia having log P 5.375, low solubility (practically insoluble in water) and low oral bioavailability (36%). Summary: This work provides a simple empirical tool using various drug-stabilizer interactions for rational selection of stabilizers. Efficient particle size reduction requires use of stabilizers that provide proper wetting of drug. Stabilizers that minimally affect intrinsic aqueous solubility of FNB resulted in lower mean particle size with better short term stability.References: A. Bhakay, M. Merwade, E. Bilgili, R.N. Dave, Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water soluble drugs, Drug Dev. Ind. Pharm. 37 (2011) 963–976
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Quantitative systems pharmacology model of Alzheimer’s disease to study efficacy of combinatorial therapy on multiple pathology components
Role of Pharmacists in Healthcare
Sania Gore, Anuja Sakpal
Description of amyloid beta influence on synaptic plasticity and tau hyperphosphorylation by mechanistic quantitative systems pharmacology model
Stepan Lerner, Tatiana Karelina
Artificial Intelligence: An Accomplishment of Modern Health Care System
Prediction and comparison of PD-1 receptor occupancy in the tumor after treatment with immune checkpoint inhibitors
Dmitry Shchelokov, Oleg Demin Jr